You just read:

Neurocrine Biosciences to Present Data Analyses Demonstrating the Long-Term Effectiveness of INGREZZA® (valbenazine) in Patients with Tardive Dyskinesia at the 2019 Annual Psych Congress

News provided by

Neurocrine Biosciences, Inc.

Oct 01, 2019, 16:01 ET